DE69503890D1 - Benzisothiazol-derivate als inhibitoren der 5-lipoxygenase biosynthese - Google Patents

Benzisothiazol-derivate als inhibitoren der 5-lipoxygenase biosynthese

Info

Publication number
DE69503890D1
DE69503890D1 DE69503890T DE69503890T DE69503890D1 DE 69503890 D1 DE69503890 D1 DE 69503890D1 DE 69503890 T DE69503890 T DE 69503890T DE 69503890 T DE69503890 T DE 69503890T DE 69503890 D1 DE69503890 D1 DE 69503890D1
Authority
DE
Germany
Prior art keywords
pct
sec
inhibitors
heterocyclic compounds
lipoxygenase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69503890T
Other languages
English (en)
Other versions
DE69503890T2 (de
Inventor
James Eggler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69503890D1 publication Critical patent/DE69503890D1/de
Application granted granted Critical
Publication of DE69503890T2 publication Critical patent/DE69503890T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
DE69503890T 1994-03-28 1995-01-18 Benzisothiazol-derivate als inhibitoren der 5-lipoxygenase biosynthese Expired - Fee Related DE69503890T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21878894A 1994-03-28 1994-03-28
PCT/IB1995/000037 WO1995026346A1 (en) 1994-03-28 1995-01-18 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis

Publications (2)

Publication Number Publication Date
DE69503890D1 true DE69503890D1 (de) 1998-09-10
DE69503890T2 DE69503890T2 (de) 1998-12-10

Family

ID=22816518

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69503890T Expired - Fee Related DE69503890T2 (de) 1994-03-28 1995-01-18 Benzisothiazol-derivate als inhibitoren der 5-lipoxygenase biosynthese

Country Status (11)

Country Link
US (1) US5665749A (de)
EP (1) EP0752990B1 (de)
JP (1) JP2841120B2 (de)
AT (1) ATE169298T1 (de)
CA (1) CA2186513C (de)
DE (1) DE69503890T2 (de)
DK (1) DK0752990T3 (de)
ES (1) ES2119377T3 (de)
FI (1) FI963882A (de)
GR (1) GR3027598T3 (de)
WO (1) WO1995026346A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
DE102005005397B4 (de) 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
EP2424521A4 (de) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd Pharmazeutische zusammensetzungen mit epa und einem kardiovaskulären mittel sowie verwendungsverfahren dafür
WO2016149126A1 (en) 2015-03-13 2016-09-22 The Board Of Trustees Of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
US11724991B1 (en) * 2023-01-06 2023-08-15 King Faisal University Selective 5-LO inhibitors for the treatment of bronchial asthma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
US5134148A (en) * 1989-02-28 1992-07-28 Imperial Chemical Industries Plc Heterocycles for use as inhibitors of leukotrienes
US5196419A (en) * 1989-02-28 1993-03-23 Imperial Chemical Industries Plc Heterocyclic cyclic ethers
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
AU637500B2 (en) * 1990-06-21 1993-05-27 Zeneca Limited Bicyclic heterocyclic compounds
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途

Also Published As

Publication number Publication date
JP2841120B2 (ja) 1998-12-24
EP0752990A1 (de) 1997-01-15
ES2119377T3 (es) 1998-10-01
MX9604429A (es) 1997-07-31
DK0752990T3 (da) 1999-02-08
ATE169298T1 (de) 1998-08-15
FI963882A0 (fi) 1996-09-27
GR3027598T3 (en) 1998-11-30
CA2186513A1 (en) 1995-10-05
WO1995026346A1 (en) 1995-10-05
US5665749A (en) 1997-09-09
JPH09507678A (ja) 1997-08-05
EP0752990B1 (de) 1998-08-05
DE69503890T2 (de) 1998-12-10
FI963882A (fi) 1996-09-27
CA2186513C (en) 1999-03-16

Similar Documents

Publication Publication Date Title
ATE187447T1 (de) 3-phenyl-2-isoxazoline derivate als entzündugshemmende mittel
ATE154932T1 (de) Isoxazolinverbindungen als entzündungshemmende mittel
SG155909A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
TW200610757A (en) New pyridazin-3(2H)-one derivatives
FI945555A (fi) Substituoituja oksindoleja
WO2000058295A3 (en) Compounds and methods for treatment of asthma, allergy and inflammatory disorders
DK0980374T3 (da) Phosphodiesterase 4-inhiberende diazepinoindoloner.
SE9900833D0 (sv) Novel combination
DE69503890T2 (de) Benzisothiazol-derivate als inhibitoren der 5-lipoxygenase biosynthese
MX9603943A (es) Compuestos de isoxazolina como inhibidores de 5-lipooxigenasa.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee